← Back to Search

Holmium Laser Enucleation of prostate for Enlarged Prostate

Phase 4
Waitlist Available
Led By Marawan M. El Tayeb, MD
Research Sponsored by Baylor Research Institute
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 months
Awards & highlights

Study Summary

This trial will test whether prescribing antibiotics after a certain prostate surgery can reduce the risk of infection. The results could change clinical practice.

Eligible Conditions
  • Enlarged Prostate
  • Urinary Tract Infection

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
the rates of urinary tract infection within the 30-day post-operative period after HoLEP
Secondary outcome measures
The incidence of irritative voiding symptoms after HoLEP and all the other urinary functional outcomes.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Patients not receiving postoperative antibioticsExperimental Treatment1 Intervention
Patients who will not receive prophylactic postoperative antibiotics after HoLEP.
Group II: Patients receiving postoperative antibioticsActive Control5 Interventions
Patients who will receive3 days prophylactic postoperative antibiotics after HoLEP.

Find a Location

Who is running the clinical trial?

Baylor Research InstituteLead Sponsor
198 Previous Clinical Trials
202,652 Total Patients Enrolled
Albert Einstein Healthcare NetworkOTHER
63 Previous Clinical Trials
868,522 Total Patients Enrolled
Marawan M. El Tayeb, MDPrincipal InvestigatorBaylor Scott and White Health Medical Center

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are recruitment efforts ongoing for this research endeavor?

"Submissions on clinicaltrials.gov confirm that this particular medical trial is no longer seeking participants, as its last update was made 9th March 2022. Nevertheless, there are currently 926 other trials in operation actively looking for patients to participate."

Answered by AI

Has the Holmium Laser Enucleation of prostate received clearance from the FDA?

"There is extensive clinical data indicating the safety of Holmium Laser Enucleation of Prostate, resulting in a score of 3 on our team's scale. This phase 4 trial confirms its efficacy and approval for use."

Answered by AI
Recent research and studies
~33 spots leftby Mar 2025